MTOR and glioblastoma: Experiments by Yu et al. demonstrated that miR-4524b-5p attenuates the progression of glioblastoma (GBM) by targeting aldehyde dehydrogenase ALDH1A3, thereby inhibiting proliferation and radio-resistance through the PI3K/AKT/mTOR signaling pathway [40].